First Time Loading...

Voyager Therapeutics Inc
NASDAQ:VYGR

Watchlist Manager
Voyager Therapeutics Inc Logo
Voyager Therapeutics Inc
NASDAQ:VYGR
Watchlist
Price: 8.81 USD 3.28% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one VYGR stock under the Base Case scenario is 3.7 USD. Compared to the current market price of 8.81 USD, Voyager Therapeutics Inc is Overvalued by 58%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VYGR Relative Value
Base Case
3.7 USD
Overvaluation 58%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
84
vs Industry
82
Median 3Y
3.2
Median 5Y
4.6
Industry
8.3
Forward
12.1
More Details
3.6
P/E
P/E
Price to Earnings
3.6
vs History
36
vs Industry
11
Median 3Y
3.4
Median 5Y
-2.3
Industry
26.8
Forward
-4.8
More Details
6.1
P/OCF
P/OCF
Price to OCF
6.1
vs History
39
vs Industry
12
Median 3Y
5.3
Median 5Y
5.3
Industry
23.3
More Details
6.4
P/FCFE
P/FCFE
Price to FCFE
6.4
vs History
39
vs Industry
10
Median 3Y
5.5
Median 5Y
5.5
Industry
21.4
More Details
2
P/B
P/B
Price to Book Value
2
vs History
76
vs Industry
46
Median 3Y
2.3
Median 5Y
3.5
Industry
2.6
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
74
vs Industry
78
Median 3Y
1.3
Median 5Y
2.1
Industry
7.5
Forward
6.2
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.2
More Details
2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
2
vs History
33
vs Industry
13
Median 3Y
1.4
Median 5Y
-0.8
Industry
4.5
Forward
-2.5
More Details
2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
2
vs History
33
vs Industry
12
Median 3Y
1.5
Median 5Y
-0.8
Industry
4.4
Forward
-2.2
More Details
3.2
EV/OCF
EV/OCF
Enterprise Value to OCF
3.2
vs History
39
vs Industry
14
Median 3Y
1.9
Median 5Y
1.9
Industry
5.6
More Details
3.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
3.3
vs History
39
vs Industry
10
Median 3Y
2
Median 5Y
2
Industry
3.4
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
73
vs Industry
49
Median 3Y
2.7
Median 5Y
4.2
Industry
5
More Details

Multiples Across Competitors

VYGR Competitors Multiples
Voyager Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Voyager Therapeutics Inc
NASDAQ:VYGR
478.4m USD 1.9 3.6 2 2
US
Abbvie Inc
NYSE:ABBV
289.2B USD 5.3 60 13 19.9
US
Amgen Inc
NASDAQ:AMGN
166.7B USD 5.9 24.8 17.9 26.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
104.7B USD 8 26.5 17.8 19.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.4B USD 10.5 28.6 22.8 23.9
AU
CSL Ltd
ASX:CSL
133.2B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD 2.9 166.8 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
47.8B USD 7 -10.1 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.7B USD 3.3 27.1 13.9 17.4
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6

See Also

Summary
VYGR intrinsic value, competitors valuation, and company profile.
DCF Valuation
VYGR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VYGR stock valuation using valuation multiples.
Wall Street Estimates
VYGR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VYGR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.